RXRX CapEx to Revenue

Recursion Pharmaceuticals Inc Clas · CapEx to Revenue

RXRX logo

RXRX CapEx to Revenue

Current (TTM)6.90%
RXRX CapEx/Revenue (228.52% → 6.90%)
High-resolution chart · PNG

RXRX capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Recursion Pharmaceuticals Inc Clas CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
8.6622%
23.2754%
27.2472%
94.1483%
397.98%
197.3337%
228.5213%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.